SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010332
Filing Date
2017-05-10
Accepted
2017-05-10 17:18:01
Documents
61
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20170331.htm 10-Q 1659234
2 EX-10.2 vktx-ex102_261.htm EX-10.2 21858
3 EX-31.1 vktx-ex311_6.htm EX-31.1 20478
4 EX-31.2 vktx-ex312_8.htm EX-31.2 20549
5 EX-32.1 vktx-ex321_7.htm EX-32.1 12819
  Complete submission text file 0001564590-17-010332.txt   7036309

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vktx-20170331.xml EX-101.INS 1575192
7 XBRL TAXONOMY EXTENSION SCHEMA vktx-20170331.xsd EX-101.SCH 54122
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20170331_cal.xml EX-101.CAL 41772
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20170331_def.xml EX-101.DEF 208254
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20170331_lab.xml EX-101.LAB 391526
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20170331_pre.xml EX-101.PRE 341528
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 17831546
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences